Publications:61
Video Visit Available
Accepting New Patients
Mount Sinai DoctorsTreats Adults
Accepting New PatientsChristopher E Walsh, MD, PhD
Internal Medicine, Hematology-Oncology, Cancer (Oncology)
No Patient Experience Ratings
Book an Appointment
About Me
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital
About Me
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital
Education
AB, Rutgers College
PhD, Bowman Gray School of Medicine
MD, Tulane University School of Medicine
Internship, Internal Medicine
Office of Graduate Medical Education
Residency, Internal Medicine
Office of Graduate Medical Education
Residency, Internal Medicine
National Cancer Institute, NIH
Fellowship, Hematology
National Cancer Institute, NIH
Certifications
American Board of Internal Medicine
Research
Dr. Walsh directs the Hemophilia Program in the Division of Hematology and Medical Oncology at Mount Sinai School of Medicine. His research focuses on gene therapy of blood diseases. Throughout his career he has had a particular interest in Fanconi anemia and his early work in this area culminated in the first clinical trial in which retroviral vectors were used for gene therapy of patients with Fanconi anemia group C. He is also actively developing gene therapies for hemophilia A and B.
Locations
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
Patients with Cigna Medicare Advantage or Humana Medicare Advantage insurance: Please read this important message before booking to find out if out-of-network costs may apply to your next visit.
- Department of Medicine - Hematology5 East 98th Street, 12th Floor, New York, NY, 10029
- Physician Office17 EAST 102ND ST, 4th floor Area D, NEW YORK, NY, 10029
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Safe and sustained overexpression of functional apolipoprotein a-i/high-density lipoprotein in apolipoprotein a-i-null mice by muscular adeno-associated viral serotype 8 vector gene transfer. Giovanni Cimmino, Wei Chen, Walter S. Speidl, Chiara Giannarelli, Borja Ibanez, Valentin Fuster, Roger Hajjar, Christopher E. Walsh, Juan J. Badimon. Journal of Cardiovascular Pharmacology
- Chimeric AAV Cap sequences alter gene transduction. Peter Ward, Christopher E. Walsh. Virology
- Factor VIII prophylaxis for adult patients with severe haemophilia A: Results of a US survey of attitudes and practices. Christopher E. Walsh, L. A. Valentino. Haemophilia
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Walsh has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Walsh has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.